NCT05990543 - Combination of Nelmastobart and Capecitabine Therapy in Metastatic Colorectal Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 29, 2024

Primary Completion Date

December 1, 2025

Study Completion Date

December 31, 2026

Conditions

Recurrent or Metastatic Colorectal Cancer

Interventions

DRUG

Nelmastobart and Capecitabine

"Nelmastobart intravenously every 3 weeks until PD or discontinuation due to toxicity. Administered on Day 1 of each cycle.~Capecitabine is administered orally for two weeks followed by a one-week rest period"

Trial Locations (1)

02841

Korea University Medical Center 73, Goryeodae-ro, Seongbuk-gu, Seoul

All Listed Sponsors

lead

Korea University Anam Hospital

OTHER